Omega-3 Market by Type (DHA, EPA, and ALA), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formula, and Pet Food & Feed), Source (Marine and Plant), and Region - Global Forecast to 2029
The global market for omega-3 is estimated at USD 7.5 billion in 2024 and is projected to reach USD 14.1 billion by 2029, at a CAGR of 13.4% during the forecast period. Ongoing research and development endeavors focused on uncovering new health benefits and applications of Omega-3 fatty acids are driving innovation and expanding the market potential for Omega-3 products. Additionally, continuous advancements in Omega-3 product formulations and delivery methods, such as microencapsulation and nanoemulsions, are improving the bioavailability, taste, and stability of Omega-3 supplements, thus attracting a wider consumer base. Furthermore, with a growing aging population worldwide, there is a heightened emphasis on healthy aging and preventive healthcare, which is fueling demand for Omega-3 supplements recognized for their potential advantages in maintaining cognitive function and joint health. Collectively, these factors contribute to the ongoing growth of the Omega-3 market.
“Increase in focus on preventive healthcare and innovative production technologies fuel demand for omega-3 market.”
As healthcare systems increasingly emphasize preventive measures to tackle the burden of chronic diseases, there's a rising recognition of the importance of Omega-3 supplements. These supplements have garnered attention for their potential to support heart health, cognitive function, and joint health. With ongoing advancements in diagnostics and personalized medicine, early detection of health risks is becoming more feasible, allowing for targeted interventions that include Omega-3 supplementation. This convergence of preventive healthcare strategies and personalized interventions is expected to fuel the growth of the Omega-3 market as individuals seek proactive approaches to manage their health and well-being.
Innovative production technologies play a vital role in the Omega-3 market by streamlining manufacturing processes, enhancing efficiency, and boosting productivity. This enables Omega-3 manufacturers to effectively address increasing consumer demand while optimizing resource utilization and lowering production costs. Moreover, these advanced methods ensure consistent quality and purity, meeting rigorous regulatory standards and consumer expectations. As a result, consumers develop trust in the reliability of Omega-3 products, leading to repeat purchases and brand loyalty. Overall, these technological advancements drive market growth by improving efficiency, quality, diversity of products, bioavailability, and sustainability. By adapting to evolving consumer demands and leveraging emerging opportunities in the health and wellness sector, manufacturers can expand their market presence and meet the needs of a broader consumer base.
“In 2023, EPA stood as the second-largest segment within the by type of omega-3 market. “
The Omega-3 market is witnessing an increasing demand for EPA (Eicosapentaenoic Acid) owing to its well-established health advantages, notably in cardiovascular health and inflammation management. As the EPA segment claims the second-largest portion of the Omega-3 market, its rising prominence emphasizes its significance in fulfilling consumer preferences for tailored health solutions. With a growing consumer inclination towards products offering specific health benefits, EPA-rich Omega-3 supplements are gaining momentum for their potential to enhance overall well-being and address diverse health needs.
“Within the source segment, plant source is expected to grow during the forecast period constantly.”
The depletion of fish stocks and the environmental repercussions of fish oil extraction are prompting consumers to seek more sustainable alternatives. Plant-based sources like algae, chia seeds, and flaxseeds offer environmentally friendly options for obtaining Omega-3 fatty acids. A growing number of individuals are embracing vegan or vegetarian lifestyles, and plant-derived Omega-3s align with their dietary preferences and ethical considerations regarding animal products. Manufacturers are continuously innovating within this sector, creating more potent and easily absorbable plant-based Omega-3 products. Examples include oils derived from microalgae and chia seed extracts encapsulated for enhanced efficacy. Investors are acknowledging the potential of this market segment, leading to heightened research and development efforts, which in turn propel further growth.
“The omega-3 market in Europe is anticipated to maintain consistent growth throughout the forecast period.”
Europe's aging population, prone to age-related health issues such as cardiovascular disease and cognitive decline, is increasingly turning to Omega-3 fatty acids for potential health benefits. Regulatory bodies like the European Food Safety Authority (EFSA) have validated health claims associated with Omega-3 fatty acids, bolstering consumer confidence and facilitating marketing efforts for Omega-3 enriched products. For instance, according to the European Union (2020), the median age in the EU-27 is projected to rise by 4.5 years between 2019 and 2050, reaching 48.2 years.
The Break-up of Primaries:
By Company Type: Tier 1 – 30%, Tier 2 – 45%, Tier 3 – 25%
By Designation: CXOs – 25%, Managers – 50%, Executives – 25%
By Region: North America – 25%, Europe – 25%, APAC – 30%, South America – 10%, and RoW - 10%
Key players in this market include BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), Croda International Plc (UK), Orkla (Norway), Corbion (Netherlands), Pelagia AS (US), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), Polaris (France), Nordic Naturals (US), and Now Foods (US).
Research Coverage:
The report segments the omega-3 market based on type, source, application, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the omega-3 market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services, key strategies, contracts, partnerships, and agreements. New product launches, mergers and acquisitions, and recent developments associated with the omega-3 market. Competitive analysis of upcoming startups in the omega-3 market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall omega-3 market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers:
“Increase in focus on preventive healthcare and innovative production technologies fuel demand for omega-3 market.”
As healthcare systems increasingly emphasize preventive measures to tackle the burden of chronic diseases, there's a rising recognition of the importance of Omega-3 supplements. These supplements have garnered attention for their potential to support heart health, cognitive function, and joint health. With ongoing advancements in diagnostics and personalized medicine, early detection of health risks is becoming more feasible, allowing for targeted interventions that include Omega-3 supplementation. This convergence of preventive healthcare strategies and personalized interventions is expected to fuel the growth of the Omega-3 market as individuals seek proactive approaches to manage their health and well-being.
Innovative production technologies play a vital role in the Omega-3 market by streamlining manufacturing processes, enhancing efficiency, and boosting productivity. This enables Omega-3 manufacturers to effectively address increasing consumer demand while optimizing resource utilization and lowering production costs. Moreover, these advanced methods ensure consistent quality and purity, meeting rigorous regulatory standards and consumer expectations. As a result, consumers develop trust in the reliability of Omega-3 products, leading to repeat purchases and brand loyalty. Overall, these technological advancements drive market growth by improving efficiency, quality, diversity of products, bioavailability, and sustainability. By adapting to evolving consumer demands and leveraging emerging opportunities in the health and wellness sector, manufacturers can expand their market presence and meet the needs of a broader consumer base.
“In 2023, EPA stood as the second-largest segment within the by type of omega-3 market. “
The Omega-3 market is witnessing an increasing demand for EPA (Eicosapentaenoic Acid) owing to its well-established health advantages, notably in cardiovascular health and inflammation management. As the EPA segment claims the second-largest portion of the Omega-3 market, its rising prominence emphasizes its significance in fulfilling consumer preferences for tailored health solutions. With a growing consumer inclination towards products offering specific health benefits, EPA-rich Omega-3 supplements are gaining momentum for their potential to enhance overall well-being and address diverse health needs.
“Within the source segment, plant source is expected to grow during the forecast period constantly.”
The depletion of fish stocks and the environmental repercussions of fish oil extraction are prompting consumers to seek more sustainable alternatives. Plant-based sources like algae, chia seeds, and flaxseeds offer environmentally friendly options for obtaining Omega-3 fatty acids. A growing number of individuals are embracing vegan or vegetarian lifestyles, and plant-derived Omega-3s align with their dietary preferences and ethical considerations regarding animal products. Manufacturers are continuously innovating within this sector, creating more potent and easily absorbable plant-based Omega-3 products. Examples include oils derived from microalgae and chia seed extracts encapsulated for enhanced efficacy. Investors are acknowledging the potential of this market segment, leading to heightened research and development efforts, which in turn propel further growth.
“The omega-3 market in Europe is anticipated to maintain consistent growth throughout the forecast period.”
Europe's aging population, prone to age-related health issues such as cardiovascular disease and cognitive decline, is increasingly turning to Omega-3 fatty acids for potential health benefits. Regulatory bodies like the European Food Safety Authority (EFSA) have validated health claims associated with Omega-3 fatty acids, bolstering consumer confidence and facilitating marketing efforts for Omega-3 enriched products. For instance, according to the European Union (2020), the median age in the EU-27 is projected to rise by 4.5 years between 2019 and 2050, reaching 48.2 years.
The Break-up of Primaries:
By Company Type: Tier 1 – 30%, Tier 2 – 45%, Tier 3 – 25%
By Designation: CXOs – 25%, Managers – 50%, Executives – 25%
By Region: North America – 25%, Europe – 25%, APAC – 30%, South America – 10%, and RoW - 10%
Key players in this market include BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), Croda International Plc (UK), Orkla (Norway), Corbion (Netherlands), Pelagia AS (US), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), Polaris (France), Nordic Naturals (US), and Now Foods (US).
Research Coverage:
The report segments the omega-3 market based on type, source, application, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the omega-3 market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services, key strategies, contracts, partnerships, and agreements. New product launches, mergers and acquisitions, and recent developments associated with the omega-3 market. Competitive analysis of upcoming startups in the omega-3 market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall omega-3 market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers:
- Analysis of key drivers (Increase in application profiling and existing applications finding new markets, innovative production technologies, and consumer awareness regarding the health benefits of omega-3), restraints (lower fish oil supply due to sustainability issues among fisheries, and lack of clarity among consumers about daily recommended intake) opportunities (microencapsulation, awareness about certified food ingredients, research for development of alternative sources to obtain omega-3), and challenges (high cost involved in R&D activities, and highly unstable fish oil prices).
- Product Development/Innovation: Detailed insights on research & development activities, and new product launches in the omega-3 market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the omega-3 market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the omega-3 market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), Croda International Plc (UK), Orkla (Norway), Corbion (Netherlands), Pelagia AS (US), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), Polaris (France), Nordic Naturals (US), Now Foods (US), BTSA (Spain), Farbest Brands (US), KinOmega Biopharm Inc (China), Pharma Marine AS (Norway), Rimfrost AS (Norway), Algarithm (Canada), Solutex (Spain), Cellana Inc (US), Nature’s Way Brands (US), and AlgaeCytes UK) among others in the omega-3 market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 REGIONAL SCOPE
1.4 YEARS CONSIDERED
1.5 UNITS CONSIDERED
1.5.1 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018–2023
1.5.2 VOLUME UNIT
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 OMEGA-3 MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.1.2.2 List of key participants in primary interviews
2.1.2.3 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 2 OMEGA-3 MARKET: DEMAND-SIDE CALCULATION
2.2.2 TOP-DOWN APPROACH
2.2.2.1 Approach to estimate market size using top-down analysis
FIGURE 3 OMEGA-3 MARKET: SUPPLY-SIDE CALCULATION
FIGURE 4 OMEGA-3 MARKET: SUPPLY SIDE
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 LIMITATIONS AND RISK ASSESSMENT
2.6 RECESSION IMPACT ANALYSIS
2.6.1 RECESSION MACROINDICATORS
FIGURE 6 INDICATORS OF RECESSION
FIGURE 7 GLOBAL INFLATION RATE, 2011–2022
FIGURE 8 GLOBAL GDP, 2011–2022 (USD TRILLION)
FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON OMEGA-3 MARKET
FIGURE 10 OMEGA-3 MARKET: EARLIER FORECAST VS. RECESSION FORECAST
3 EXECUTIVE SUMMARY
TABLE 2 OMEGA-3 MARKET SNAPSHOT, 2024 VS. 2029
FIGURE 11 OMEGA-3 MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 12 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 13 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
FIGURE 14 OMEGA-3 MARKET: REGIONAL SHARE, 2023
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET
FIGURE 15 RISING CHRONIC DISEASES TO DRIVE MARKET GROWTH
4.2 OMEGA-3 MARKET IN ASIA PACIFIC, BY TYPE AND KEY COUNTRIES
FIGURE 16 DOCOSAHEXAENOIC ACID SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES OF ASIA PACIFIC MARKET IN 2023
4.3 OMEGA-3 MARKET, BY APPLICATION
FIGURE 17 DIETARY SUPPLEMENT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 OMEGA-3 MARKET, BY TYPE
FIGURE 18 DOCOSAHEXAENOIC ACID SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE FROM 2024 TO 2029
4.5 OMEGA-3 MARKET, BY SOURCE
FIGURE 19 MARINE SEGMENT TO CLAIM LARGER MARKET SHARE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 PREVENTIVE HEALTHCARE EXPENDITURE
FIGURE 20 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP, BY COUNTRY, 2020
5.2.2 GROWING GERIATRIC POPULATION
FIGURE 21 POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION), 2012–2022
5.3 MARKET DYNAMICS
FIGURE 22 MARKET DYNAMICS: OMEGA-3 MARKET
5.3.1 DRIVERS
5.3.1.1 Growing consumer awareness regarding health benefits of omega-3
TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION
5.3.1.2 Increasing use of omega-3 fatty acids in food and feed products
5.3.1.2.1 Rising demand for mother & infant nutrition products
TABLE 4 INFANT FORMULA CONSTITUENTS OF KEY BRANDS (PER 100 GM)
5.3.1.2.2 Growth focus of food processing companies on fortification
5.3.1.2.3 Increasing applications in pet food and feed
FIGURE 23 RECOMMENDED EPA LEVELS IN DOG FOOD (MG)
5.3.1.3 Growing adoption of innovative production technologies
5.3.2 RESTRAINTS
5.3.2.1 Lower fish oil supply due to sustainability issues among fisheries
5.3.2.2 Lack of clarity among consumers about daily recommended intake and health claims
TABLE 5 EPA AND DHA DAILY INTAKE GUIDELINES BY VARIOUS ORGANIZATIONS
5.3.3 OPPORTUNITIES
5.3.3.1 Increasing research for development of alternative sources to obtain omega-3
TABLE 6 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS
5.3.3.1.1 Rising consumer demand for plant-based products
5.3.3.1.1.1 Growing focus on microalgae-based omega-3 production
FIGURE 24 MICROALGAE PROCESSING FOR OMEGA-3
5.3.3.1.1.2 Side-effects and allergies related to fish-based products
5.3.3.2 Favorable regulatory environment
5.3.3.3 Application of microencapsulation technology to regulate release of nutrients in fortified food & beverages
5.3.4 CHALLENGES
5.3.4.1 High costs involved in R&D activities
5.3.4.2 Highly unstable fish oil prices
5.3.4.3 Instability of omega-3 oils
5.4 INVESTMENT AND FUNDING SCENARIO
FIGURE 25 OMEGA-3 MARKET: INVESTOR DEALS AND FUNDING
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.2.1 RESEARCH & PRODUCT DEVELOPMENT
6.2.2 MANUFACTURING
6.2.3 MARKETING & SALES
6.2.4 DISTRIBUTION
6.2.5 POST-SALES SERVICES
FIGURE 26 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS
6.3 TECHNOLOGY ANALYSIS
6.3.1 MOLECULAR DISTILLATION
6.3.2 ALGAE FERMENTATION
6.4 PATENT ANALYSIS
FIGURE 27 KEY PATENTS GRANTED IN OMEGA-3 MARKET, 2014–2024
FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED IN OMEGA-3 MARKET,
2014–2024
6.4.1 LIST OF MAJOR PATENTS PERTAINING TO OMEGA-3 MARKET (2014–2023)
6.5 ECOSYSTEM ANALYSIS
6.5.1 DEMAND SIDE
6.5.2 SUPPLY SIDE
TABLE 7 ROLE OF PARTICIPANTS IN ECOSYSTEM
FIGURE 29 OMEGA-3 MARKET: ECOSYSTEM ANALYSIS
6.6 TRADE ANALYSIS
6.6.1 EXPORT DATA
TABLE 8 EXPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION)
6.6.2 IMPORT DATA
TABLE 9 IMPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION)
6.7 PRICING ANALYSIS
6.7.1 AVERAGE SELLING PRICE TREND OF PRODUCTS OFFERED BY KEY PLAYERS, BY SOURCE
TABLE 10 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PRODUCTS OFFERED BY KEY PLAYERS, BY SOURCE, 2023 (USD/KG)
6.7.2 AVERAGE SELLING PRICE TREND OF OMEGA-3, BY SOURCE
TABLE 11 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF OMEGA-3, BY SOURCE, 2019–2023 (USD/KG)
6.7.3 AVERAGE SELLING PRICE TREND OF MARINE SOURCES, BY REGION
TABLE 12 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF MARINE SOURCES, BY REGION, 2019–2023 (USD/KG)
6.7.4 AVERAGE SELLING PRICE TREND OF PLANT SOURCES, BY REGION
TABLE 13 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PLANT SOURCES, BY REGION, 2019–2023 (USD/KG)
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 30 TRENDS INFLUENCING OMEGA-3 MARKET
6.9 KEY CONFERENCES AND EVENTS, 2024
TABLE 14 OMEGA-3 MARKET: LIST OF CONFERENCES AND EVENTS, 2023–2024
6.10 REGULATORY LANDSCAPE
6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.10.2 REGULATORY LANDSCAPE
6.10.2.1 North America
6.10.2.1.1 US
6.10.2.1.2 Canada
6.10.2.2 Europe
6.10.2.3 Asia Pacific
6.10.2.3.1 China
6.10.2.3.2 Japan
6.10.2.3.3 India
6.10.2.4 South America
6.10.2.4.1 Brazil
6.10.2.4.2 Argentina
6.10.2.4.3 Chile
6.10.2.5 RoW
6.10.2.5.1 South Africa
6.10.2.5.2 UAE
6.11 CASE STUDY ANALYSIS
6.11.1 VERAMARIS ASSISTED BLAIR IN PRODUCING OMEGA-3 FATTY ACIDS FROM NATURAL MARINE ALGAE
6.11.2 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
6.11.3 OMEGA-3 SUPPLEMENTS HELPED REDUCE SEIZURE FREQUENCY IN GREAT DANE SUFFERING FROM REFRACTORY CANINE EPILEPSY
6.12 PORTER'S FIVE FORCES ANALYSIS
TABLE 18 PORTER'S FIVE FORCES ANALYSIS
6.12.1 INTENSITY OF COMPETITIVE RIVALRY
6.12.2 BARGAINING POWER OF SUPPLIERS
6.12.3 BARGAINING POWER OF BUYERS
6.12.4 THREAT OF SUBSTITUTES
6.12.5 THREAT OF NEW ENTRANTS
6.13 KEY STAKEHOLDERS & BUYING CRITERIA
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE (%)
6.13.2 BUYING CRITERIA
FIGURE 32 BUYING CRITERIA
TABLE 20 KEY BUYING CRITERIA FOR SOURCE SEGMENT
7 OMEGA-3 MARKET, BY TYPE
7.1 INTRODUCTION
FIGURE 33 DOCOSAHEXAENOIC ACID SEGMENT TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD
TABLE 21 OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 22 OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
7.2 DOCOSAHEXAENOIC ACID
7.2.1 LOWERED RISK OF ALZHEIMER'S DISEASE TO DRIVE MARKET GROWTH
TABLE 23 FOOD SOURCES FOR DHA (GRAMS PER SERVING)
TABLE 24 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 25 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
7.3 EICOSAPENTAENOIC ACID
7.3.1 REDUCED SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND
TABLE 26 FOOD SOURCES FOR EPA (GRAMS PER SERVING)
TABLE 27 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 28 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
7.4 ALPHA-LINOLENIC ACID
7.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND
TABLE 29 FOOD SOURCES FOR ALA (GRAMS PER SERVING)
TABLE 30 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 31 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
8 OMEGA-3 MARKET, BY SOURCE
8.1 INTRODUCTION
FIGURE 34 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
TABLE 32 OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 33 OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 34 OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 35 OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
8.2 MARINE
8.2.1 SURGING DEMAND AMONG PREGNANT WOMEN FOR HEALTHY FETAL DEVELOPMENT TO DRIVE MARKET
TABLE 36 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS
TABLE 37 MARINE: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 38 MARINE: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 39 MARINE: OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
TABLE 40 MARINE: OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
TABLE 41 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2019–2023 (USD MILLION)
TABLE 42 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2024–2029 (USD MILLION)
8.3 PLANT
8.3.1 GROWING USE OF FLAX SEEDS TO PREVENT CANCER TO BOOST DEMAND
TABLE 43 PLANT: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 44 PLANT: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 45 PLANT: OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
TABLE 46 PLANT: OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
TABLE 47 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2019–2023 (USD MILLION)
TABLE 48 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2024–2029 (USD MILLION)
9 OMEGA-3 MARKET, BY APPLICATION
9.1 INTRODUCTION
FIGURE 35 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
TABLE 49 OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 50 OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
9.2 DIETARY SUPPLEMENT
9.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIET TO DRIVE MARKET
TABLE 51 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 52 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
9.3 FUNCTIONAL FOOD & BEVERAGE
9.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND
TABLE 53 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 54 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
9.4 PHARMACEUTICAL
9.4.1 GROWING APPLICATION TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET
TABLE 55 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 56 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
9.5 INFANT FORMULA
9.5.1 RISING CONSUMPTION OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND
TABLE 57 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 58 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
9.6 PET FOOD AND FEED
9.6.1 GREATER EMPHASIS ON BUILDING STRONG IMMUNITY IN PETS TO DRIVE MARKET
TABLE 59 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 60 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
10 OMEGA-3 MARKET, BY REGION
10.1 INTRODUCTION
FIGURE 36 INDIA TO RECORD FASTEST GROWTH IN GLOBAL OMEGA-3 MARKET
TABLE 61 OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 62 OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 63 OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
TABLE 64 OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
10.2 NORTH AMERICA
FIGURE 37 NORTH AMERICA: REGIONAL SNAPSHOT
10.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 38 OMEGA-3 MARKET IN NORTH AMERICA: RECESSION IMPACT ANALYSIS
TABLE 65 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 66 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 67 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 68 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 69 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 70 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 71 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 72 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 73 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 74 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
10.2.2 US
10.2.2.1 Growing demand for plant-based omega-3 dietary supplements to drive market
TABLE 75 US: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 76 US: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 77 US: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 78 US: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 79 US: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 80 US: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 81 US: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Increased application in functional food & beverages to boost demand
TABLE 82 CANADA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 83 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 84 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 85 CANADA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 86 CANADA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 87 CANADA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 88 CANADA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.2.4 MEXICO
10.2.4.1 Growing focus on preventing heart diseases to drive market
TABLE 89 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 90 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 91 MEXICO: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 92 MEXICO: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 93 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 94 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
FIGURE 39 OMEGA-3 MARKET IN EUROPE: RECESSION IMPACT ANALYSIS
TABLE 95 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 96 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 97 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 98 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 99 EUROPE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 100 EUROPE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 101 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 102 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 103 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 104 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
10.3.2 GERMANY
10.3.2.1 Less fish consumption to boost demand for omega-3-based supplements
TABLE 105 GERMANY: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 106 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 107 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 108 GERMANY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 109 GERMANY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 110 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 111 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.3 UK
10.3.3.1 Ability to boost brain function and reduce inflammation to drive market
TABLE 112 UK: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 113 UK: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 114 UK: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 115 UK: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 116 UK: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 117 UK: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 118 UK: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Ongoing innovations to boost quality and stability of omega-3-rich oils formulation to drive market
TABLE 119 FRANCE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 120 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 121 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 122 FRANCE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 123 FRANCE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 124 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 125 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.5 NORWAY
10.3.5.1 Production of genetically modified canola to offer lucrative growth opportunities to players
TABLE 126 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 127 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 128 NORWAY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 129 NORWAY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 130 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 131 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.6 ITALY
10.3.6.1 High production of dietary supplements, functional food products, and beverages to boost demand
TABLE 132 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 133 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 134 ITALY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 135 ITALY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 136 ITALY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 137 ITALY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.7 SPAIN
10.3.7.1 Need for sufficient consumption of ALA, DHA and EPA from foods to accelerate demand
TABLE 138 SPAIN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 139 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 140 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 141 SPAIN: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 142 SPAIN: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 143 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 144 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.8 NETHERLANDS
10.3.8.1 Growing incidences of depression, autism, and ADHD to drive market
TABLE 145 NETHERLANDS: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 146 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 147 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 148 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 149 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 150 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 151 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.9 REST OF EUROPE
TABLE 152 REST OF EUROPE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 153 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 154 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 155 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 156 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 157 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 158 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 40 ASIA PACIFIC: REGIONAL SNAPSHOT
10.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 41 OMEGA-3 MARKET IN ASIA PACIFIC: RECESSION IMPACT ANALYSIS
TABLE 159 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 160 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 161 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 162 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 163 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 164 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
10.4.2 CHINA
10.4.2.1 Increasing focus on product innovations and diversifications to drive market
TABLE 169 CHINA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 170 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 171 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 172 CHINA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 173 CHINA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 174 CHINA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 175 CHINA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing incidences of heart failure to drive market
TABLE 176 INDIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 177 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 178 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 179 INDIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 180 INDIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 181 INDIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 182 INDIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4.4 JAPAN
10.4.4.1 Rising use of innovative formulation technology to create opportunities for manufacturers of omega-3 products
TABLE 183 JAPAN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 184 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 185 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 186 JAPAN: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 187 JAPAN: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 188 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 189 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Government-led initiatives to increase awareness regarding omega-3 to drive market
TABLE 190 AUSTRALIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 191 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 192 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 193 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 194 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 195 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 196 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4.6 NEW ZEALAND
10.4.6.1 Increasing consumer awareness and government regulations for omega-3 supplements to drive market growth
TABLE 197 NEW ZEALAND: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 198 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 199 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 200 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 201 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 202 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 203 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 204 REST OF ASIA PACIFIC: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 205 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 206 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 207 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 208 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 209 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 210 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.5 SOUTH AMERICA
10.5.1 SOUTH AMERICA: RECESSION IMPACT
FIGURE 42 OMEGA-3 MARKET IN SOUTH AMERIC: RECESSION IMPACT ANALYSIS, 2023
TABLE 211 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 212 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 213 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 214 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 215 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 216 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 217 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 218 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 219 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 220 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
10.5.2 BRAZIL
10.5.2.1 Rising demand for algal oils to drive market
TABLE 221 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 222 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 223 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 224 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 225 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 226 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.5.3 ARGENTINA
10.5.3.1 Commercialization of omega-3 products to fuel market growth
TABLE 227 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 228 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 229 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 230 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 231 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 232 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.5.4 REST OF SOUTH AMERICA
TABLE 233 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 234 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 235 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 236 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 237 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 238 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6 ROW
10.6.1 ROW: RECESSION IMPACT
FIGURE 43 OMEGA-3 MARKET IN ROW: RECESSION IMPACT ANALYSIS
TABLE 239 ROW: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 240 ROW: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 241 ROW: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 242 ROW: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 243 ROW: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 244 ROW: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 245 ROW: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 246 ROW: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 247 ROW: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 248 ROW: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
10.6.2 AFRICA
TABLE 249 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 250 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 251 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 252 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 253 AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 254 AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 255 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 256 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.2.1 South Africa
10.6.2.1.1 Prevalence of undernutrition among pregnant women and kids to drive demand
TABLE 257 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 258 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 259 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 260 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 261 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 262 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.2.2 Egypt
10.6.2.2.1 Improved pediatric health conditions to boost demand
TABLE 263 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 264 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 265 EGYPT: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 266 EGYPT: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 267 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 268 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.2.3 Nigeria
10.6.2.3.1 Rising prevalnce of artery diseases to boost demand
TABLE 269 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 270 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 271 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 272 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 273 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 274 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.2.4 Rest of Africa
TABLE 275 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 276 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 277 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 278 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 279 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 280 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.3 MIDDLE EAST
TABLE 281 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 282 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 283 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 284 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 285 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 286 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 287 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 288 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.3.1 Saudi Arabia
10.6.3.1.1 Ongoing innovations in omega-3 products to drive market
TABLE 289 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 290 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 291 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 292 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 293 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 294 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.3.2 UAE
10.6.3.2.1 Increasing awareness among consumers about health products to drive market
TABLE 295 UAE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 296 UAE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 297 UAE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 298 UAE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 299 UAE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 300 UAE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.3.3 Qatar
10.6.3.3.1 Growing research on algae to boost demand
TABLE 301 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 302 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 303 QATAR: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 304 QATAR: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 305 QATAR: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 306 QATAR: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.3.4 Rest of Middle East
TABLE 307 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 308 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 309 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 310 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 311 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 312 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, 2022
TABLE 313 OMEGA-3 MARKET: DEGREE OF COMPETITION
11.3 KEY PLAYERS STRATEGIES/RIGHT TO WIN, 2020–2024
TABLE 314 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET, 2020–2024
11.4 BRAND/PRODUCT ANALYSIS
FIGURE 44 BRAND/PRODUCT ANALYSIS FOR KEY BRANDS
11.5 SEGMENTAL REVENUE ANALYSIS, 2020–2022
FIGURE 45 THREE-YEAR SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN OMEGA-3 MARKET (USD BILLION)
11.6 KEY PLAYERS’ ANNUAL REVENUE, 2022 VS. REVENUE GROWTH, 2020–2022
FIGURE 46 ANNUAL REVENUE, 2022 (USD BILLION) VS. REVENUE GROWTH (%), 2020–2022
11.7 EBIT/EBITDA ANALYSIS, 2022
FIGURE 47 EBIT/EBITDA (USD BILLION)
11.8 GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS, 2022
FIGURE 48 GLOBAL SNAPSHOT OF KEY PARTICIPANTS
11.9 COMPANY VALUATION AND FINANCIAL METRICS
FIGURE 49 COMPANY VALUATION OF FEW MAJOR COMPANIES
FIGURE 50 EV/EBITDA OF KEY COMPANIES
11.10 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2022
11.10.1 STARS
11.10.2 EMERGING LEADERS
11.10.3 PERVASIVE PLAYERS
11.10.4 PARTICIPANTS
FIGURE 51 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
11.10.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.10.5.1 Company footprint
TABLE 315 OVERALL COMPANY FOOTPRINT
11.10.5.2 Type footprint
TABLE 316 OMEGA-3 MARKET: BY TYPE FOOTPRINT
11.10.5.3 Source footprint
TABLE 317 OMEGA-3 MARKET: BY SOURCE FOOTPRINT
11.10.5.4 Application footprint
TABLE 318 OMEGA-3 MARKET: BY APPLICATION FOOTPRINT
11.10.5.5 Region footprint
TABLE 319 OMEGA-3 MARKET: BY REGION FOOTPRINT
11.11 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2022
11.11.1 PROGRESSIVE COMPANIES
11.11.2 RESPONSIVE COMPANIES
11.11.3 DYNAMIC COMPANIES
11.11.4 STARTING BLOCKS
FIGURE 52 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2022
11.11.5 COMPETITIVE BENCHMARKING, START-UPS/SMES, 2023
11.11.5.1 List of key start-ups/SMEs
TABLE 320 OMEGA-3 MARKET: LIST OF KEY START-UPS/SMES
11.11.5.2 Competitive benchmarking of key start-ups/SMEs
TABLE 321 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
11.12 COMPETITIVE SCENARIO
11.12.1 PRODUCT LAUNCHES
TABLE 322 OMEGA-3 MARKET: PRODUCT LAUNCHES, JANUARY 2020– FEBRUARY 2024
11.12.2 DEALS
TABLE 323 OMEGA-3 MARKET: DEALS, JANUARY 2020– FEBRUARY 2024
11.12.3 EXPANSIONS
TABLE 324 OMEGA-3 MARKET: EXPANSIONS, JANUARY 2020– FEBRUARY 2024
11.12.4 OTHERS
TABLE 325 OMEGA-3 MARKET: OTHERS, JANUARY 2020– FEBRUARY 2024
12 COMPANY PROFILES
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS
12.1.1 BASF SE
TABLE 326 BASF SE: COMPANY OVERVIEW
FIGURE 53 BASF SE: COMPANY SNAPSHOT
TABLE 327 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 328 BASF SE: PRODUCT LAUNCHES
12.1.2 CARGILL, INCORPORATED
TABLE 329 CARGILL, INCORPORATED: COMPANY OVERVIEW
FIGURE 54 CARGILL, INCORPORATED.: COMPANY SNAPSHOT
TABLE 330 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 331 CARGILL, INCORPORATED: DEALS
12.1.3 DSM-FIRMENICH
TABLE 332 DSM-FIRMENICH: COMPANY OVERVIEW
FIGURE 55 DSM-FIRMENICH: COMPANY SNAPSHOT
TABLE 333 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 334 DSM-FIRMENICH: PRODUCT LAUNCHES
12.1.4 ADM
TABLE 335 ADM: COMPANY OVERVIEW
FIGURE 56 ADM: COMPANY SNAPSHOT
TABLE 336 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.1.5 KERRY GROUP PLC
TABLE 337 KERRY GROUP PLC: BUSINESS OVERVIEW
FIGURE 57 KERRY GROUP PLC: COMPANY SNAPSHOT
TABLE 338 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 339 KERRY GROUP PLC: DEALS
12.1.6 CRODA INTERNATIONAL PLC
TABLE 340 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW
FIGURE 58 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
TABLE 341 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.1.7 ORKLA
TABLE 342 ORKLA: COMPANY OVERVIEW
FIGURE 59 ORKLA: COMPANY SNAPSHOT
TABLE 343 ORKLA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 344 ORKLA: DEALS
12.1.8 CORBION
TABLE 345 CORBION: COMPANY OVERVIEW
FIGURE 60 CORBION: COMPANY SNAPSHOT
TABLE 346 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 347 CORBION: PRODUCT LAUNCHES
TABLE 348 CORBION: EXPANSIONS
12.1.9 PELAGIA AS
TABLE 349 PELAGIA AS: COMPANY OVERVIEW
FIGURE 61 PELAGIA AS: COMPANY SNAPSHOT
TABLE 350 PELAGIA AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 351 PELAGIA AS: DEALS
12.1.10 KD PHARMA GROUP SA
TABLE 352 KD PHARMA GROUP SA: COMPANY OVERVIEW
TABLE 353 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 354 KD PHARMA GROUP SA: EXPANSIONS
12.1.11 GC RIEBER
TABLE 355 GC RIEBER: COMPANY OVERVIEW
TABLE 356 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 357 GC RIEBER: PRODUCT LAUNCHES
TABLE 358 GC REIBER: DEALS
TABLE 359 GC RIEBER: EXPANSIONS
12.1.12 COOKE AQUACULTURE INC.
TABLE 360 COOKE AQUACULTURE INC.: COMPANY OVERVIEW
TABLE 361 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 362 COOKE AQUACULTURE INC.: DEALS
12.1.13 ALGISYS BIOSCIENCES, INC.
TABLE 363 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW
TABLE 364 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 365 ALGISYS BIOSCIENCES, INC.: OTHERS
12.1.14 GOLDEN OMEGA
TABLE 366 GOLDEN OMEGA: COMPANY OVERVIEW
TABLE 367 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 368 GOLDEN OMEGA: DEALS
12.1.15 POLARIS
TABLE 369 POLARIS: COMPANY OVERVIEW
TABLE 370 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 371 POLARIS: PRODUCT LAUNCHES
TABLE 372 POLARIS: OTHERS
12.2 OTHER PLAYERS
12.2.1 BTSA
TABLE 373 BTSA: COMPANY OVERVIEW
TABLE 374 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.2.2 FARBEST BRANDS
TABLE 375 FARBEST BRANDS: COMPANY OVERVIEW
TABLE 376 FARBEST BRANDS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.2.3 KINOMEGA BIOPHARM INC.
TABLE 377 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW
TABLE 378 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.2.4 PHARMA MARINE AS
TABLE 379 PHARMA MARINE AS: COMPANY OVERVIEW
TABLE 380 PHARMA MARINE AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.2.5 RIMFROST AS
TABLE 381 RIMFROST AS: COMPANY OVERVIEW
TABLE 382 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 383 RIMFROST AS: DEALS
12.2.6 ALGARITHM
12.2.7 SOLUTEX
12.2.8 CELLANA INC.
12.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD
12.2.10 ALGAECYTES
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 ADJACENT AND RELATED MARKETS
13.1 INTRODUCTION
TABLE 384 ADJACENT MARKETS
13.2 LIMITATIONS
13.3 COLLAGEN MARKET
13.3.1 MARKET DEFINITION
13.3.2 MARKET OVERVIEW
TABLE 385 COLLAGEN MARKET, BY FORM, 2019–2022 (USD MILLION)
TABLE 386 COLLAGEN MARKET, BY FORM, 2023–2030 (USD MILLION)
13.4 ALGAE PRODUCTS MARKET
13.4.1 MARKET DEFINITION
13.4.2 MARKET OVERVIEW
TABLE 387 ALGAE PRODUCTS MARKET, BY SOURCE, 2018–2022 (USD MILLION)
TABLE 388 ALGAE PRODUCTS MARKET, BY SOURCE, 2023–2028 (USD MILLION)
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 REGIONAL SCOPE
1.4 YEARS CONSIDERED
1.5 UNITS CONSIDERED
1.5.1 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018–2023
1.5.2 VOLUME UNIT
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 OMEGA-3 MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.1.2.2 List of key participants in primary interviews
2.1.2.3 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 2 OMEGA-3 MARKET: DEMAND-SIDE CALCULATION
2.2.2 TOP-DOWN APPROACH
2.2.2.1 Approach to estimate market size using top-down analysis
FIGURE 3 OMEGA-3 MARKET: SUPPLY-SIDE CALCULATION
FIGURE 4 OMEGA-3 MARKET: SUPPLY SIDE
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 LIMITATIONS AND RISK ASSESSMENT
2.6 RECESSION IMPACT ANALYSIS
2.6.1 RECESSION MACROINDICATORS
FIGURE 6 INDICATORS OF RECESSION
FIGURE 7 GLOBAL INFLATION RATE, 2011–2022
FIGURE 8 GLOBAL GDP, 2011–2022 (USD TRILLION)
FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON OMEGA-3 MARKET
FIGURE 10 OMEGA-3 MARKET: EARLIER FORECAST VS. RECESSION FORECAST
3 EXECUTIVE SUMMARY
TABLE 2 OMEGA-3 MARKET SNAPSHOT, 2024 VS. 2029
FIGURE 11 OMEGA-3 MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 12 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 13 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
FIGURE 14 OMEGA-3 MARKET: REGIONAL SHARE, 2023
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET
FIGURE 15 RISING CHRONIC DISEASES TO DRIVE MARKET GROWTH
4.2 OMEGA-3 MARKET IN ASIA PACIFIC, BY TYPE AND KEY COUNTRIES
FIGURE 16 DOCOSAHEXAENOIC ACID SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARES OF ASIA PACIFIC MARKET IN 2023
4.3 OMEGA-3 MARKET, BY APPLICATION
FIGURE 17 DIETARY SUPPLEMENT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 OMEGA-3 MARKET, BY TYPE
FIGURE 18 DOCOSAHEXAENOIC ACID SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE FROM 2024 TO 2029
4.5 OMEGA-3 MARKET, BY SOURCE
FIGURE 19 MARINE SEGMENT TO CLAIM LARGER MARKET SHARE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 PREVENTIVE HEALTHCARE EXPENDITURE
FIGURE 20 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP, BY COUNTRY, 2020
5.2.2 GROWING GERIATRIC POPULATION
FIGURE 21 POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION), 2012–2022
5.3 MARKET DYNAMICS
FIGURE 22 MARKET DYNAMICS: OMEGA-3 MARKET
5.3.1 DRIVERS
5.3.1.1 Growing consumer awareness regarding health benefits of omega-3
TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION
5.3.1.2 Increasing use of omega-3 fatty acids in food and feed products
5.3.1.2.1 Rising demand for mother & infant nutrition products
TABLE 4 INFANT FORMULA CONSTITUENTS OF KEY BRANDS (PER 100 GM)
5.3.1.2.2 Growth focus of food processing companies on fortification
5.3.1.2.3 Increasing applications in pet food and feed
FIGURE 23 RECOMMENDED EPA LEVELS IN DOG FOOD (MG)
5.3.1.3 Growing adoption of innovative production technologies
5.3.2 RESTRAINTS
5.3.2.1 Lower fish oil supply due to sustainability issues among fisheries
5.3.2.2 Lack of clarity among consumers about daily recommended intake and health claims
TABLE 5 EPA AND DHA DAILY INTAKE GUIDELINES BY VARIOUS ORGANIZATIONS
5.3.3 OPPORTUNITIES
5.3.3.1 Increasing research for development of alternative sources to obtain omega-3
TABLE 6 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS
5.3.3.1.1 Rising consumer demand for plant-based products
5.3.3.1.1.1 Growing focus on microalgae-based omega-3 production
FIGURE 24 MICROALGAE PROCESSING FOR OMEGA-3
5.3.3.1.1.2 Side-effects and allergies related to fish-based products
5.3.3.2 Favorable regulatory environment
5.3.3.3 Application of microencapsulation technology to regulate release of nutrients in fortified food & beverages
5.3.4 CHALLENGES
5.3.4.1 High costs involved in R&D activities
5.3.4.2 Highly unstable fish oil prices
5.3.4.3 Instability of omega-3 oils
5.4 INVESTMENT AND FUNDING SCENARIO
FIGURE 25 OMEGA-3 MARKET: INVESTOR DEALS AND FUNDING
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.2.1 RESEARCH & PRODUCT DEVELOPMENT
6.2.2 MANUFACTURING
6.2.3 MARKETING & SALES
6.2.4 DISTRIBUTION
6.2.5 POST-SALES SERVICES
FIGURE 26 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS
6.3 TECHNOLOGY ANALYSIS
6.3.1 MOLECULAR DISTILLATION
6.3.2 ALGAE FERMENTATION
6.4 PATENT ANALYSIS
FIGURE 27 KEY PATENTS GRANTED IN OMEGA-3 MARKET, 2014–2024
FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED IN OMEGA-3 MARKET,
2014–2024
6.4.1 LIST OF MAJOR PATENTS PERTAINING TO OMEGA-3 MARKET (2014–2023)
6.5 ECOSYSTEM ANALYSIS
6.5.1 DEMAND SIDE
6.5.2 SUPPLY SIDE
TABLE 7 ROLE OF PARTICIPANTS IN ECOSYSTEM
FIGURE 29 OMEGA-3 MARKET: ECOSYSTEM ANALYSIS
6.6 TRADE ANALYSIS
6.6.1 EXPORT DATA
TABLE 8 EXPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION)
6.6.2 IMPORT DATA
TABLE 9 IMPORT VALUE OF OMEGA-3, BY KEY COUNTRY, 2022 (USD MILLION)
6.7 PRICING ANALYSIS
6.7.1 AVERAGE SELLING PRICE TREND OF PRODUCTS OFFERED BY KEY PLAYERS, BY SOURCE
TABLE 10 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PRODUCTS OFFERED BY KEY PLAYERS, BY SOURCE, 2023 (USD/KG)
6.7.2 AVERAGE SELLING PRICE TREND OF OMEGA-3, BY SOURCE
TABLE 11 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF OMEGA-3, BY SOURCE, 2019–2023 (USD/KG)
6.7.3 AVERAGE SELLING PRICE TREND OF MARINE SOURCES, BY REGION
TABLE 12 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF MARINE SOURCES, BY REGION, 2019–2023 (USD/KG)
6.7.4 AVERAGE SELLING PRICE TREND OF PLANT SOURCES, BY REGION
TABLE 13 OMEGA-3 MARKET: AVERAGE SELLING PRICE (ASP) TREND OF PLANT SOURCES, BY REGION, 2019–2023 (USD/KG)
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 30 TRENDS INFLUENCING OMEGA-3 MARKET
6.9 KEY CONFERENCES AND EVENTS, 2024
TABLE 14 OMEGA-3 MARKET: LIST OF CONFERENCES AND EVENTS, 2023–2024
6.10 REGULATORY LANDSCAPE
6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.10.2 REGULATORY LANDSCAPE
6.10.2.1 North America
6.10.2.1.1 US
6.10.2.1.2 Canada
6.10.2.2 Europe
6.10.2.3 Asia Pacific
6.10.2.3.1 China
6.10.2.3.2 Japan
6.10.2.3.3 India
6.10.2.4 South America
6.10.2.4.1 Brazil
6.10.2.4.2 Argentina
6.10.2.4.3 Chile
6.10.2.5 RoW
6.10.2.5.1 South Africa
6.10.2.5.2 UAE
6.11 CASE STUDY ANALYSIS
6.11.1 VERAMARIS ASSISTED BLAIR IN PRODUCING OMEGA-3 FATTY ACIDS FROM NATURAL MARINE ALGAE
6.11.2 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
6.11.3 OMEGA-3 SUPPLEMENTS HELPED REDUCE SEIZURE FREQUENCY IN GREAT DANE SUFFERING FROM REFRACTORY CANINE EPILEPSY
6.12 PORTER'S FIVE FORCES ANALYSIS
TABLE 18 PORTER'S FIVE FORCES ANALYSIS
6.12.1 INTENSITY OF COMPETITIVE RIVALRY
6.12.2 BARGAINING POWER OF SUPPLIERS
6.12.3 BARGAINING POWER OF BUYERS
6.12.4 THREAT OF SUBSTITUTES
6.12.5 THREAT OF NEW ENTRANTS
6.13 KEY STAKEHOLDERS & BUYING CRITERIA
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY SOURCE (%)
6.13.2 BUYING CRITERIA
FIGURE 32 BUYING CRITERIA
TABLE 20 KEY BUYING CRITERIA FOR SOURCE SEGMENT
7 OMEGA-3 MARKET, BY TYPE
7.1 INTRODUCTION
FIGURE 33 DOCOSAHEXAENOIC ACID SEGMENT TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD
TABLE 21 OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 22 OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
7.2 DOCOSAHEXAENOIC ACID
7.2.1 LOWERED RISK OF ALZHEIMER'S DISEASE TO DRIVE MARKET GROWTH
TABLE 23 FOOD SOURCES FOR DHA (GRAMS PER SERVING)
TABLE 24 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 25 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
7.3 EICOSAPENTAENOIC ACID
7.3.1 REDUCED SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND
TABLE 26 FOOD SOURCES FOR EPA (GRAMS PER SERVING)
TABLE 27 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 28 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
7.4 ALPHA-LINOLENIC ACID
7.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND
TABLE 29 FOOD SOURCES FOR ALA (GRAMS PER SERVING)
TABLE 30 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 31 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
8 OMEGA-3 MARKET, BY SOURCE
8.1 INTRODUCTION
FIGURE 34 OMEGA-3 MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
TABLE 32 OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 33 OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 34 OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 35 OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
8.2 MARINE
8.2.1 SURGING DEMAND AMONG PREGNANT WOMEN FOR HEALTHY FETAL DEVELOPMENT TO DRIVE MARKET
TABLE 36 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS
TABLE 37 MARINE: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 38 MARINE: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 39 MARINE: OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
TABLE 40 MARINE: OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
TABLE 41 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2019–2023 (USD MILLION)
TABLE 42 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2024–2029 (USD MILLION)
8.3 PLANT
8.3.1 GROWING USE OF FLAX SEEDS TO PREVENT CANCER TO BOOST DEMAND
TABLE 43 PLANT: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 44 PLANT: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 45 PLANT: OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
TABLE 46 PLANT: OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
TABLE 47 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2019–2023 (USD MILLION)
TABLE 48 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2024–2029 (USD MILLION)
9 OMEGA-3 MARKET, BY APPLICATION
9.1 INTRODUCTION
FIGURE 35 OMEGA-3 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
TABLE 49 OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 50 OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
9.2 DIETARY SUPPLEMENT
9.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIET TO DRIVE MARKET
TABLE 51 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 52 DIETARY SUPPLEMENT: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
9.3 FUNCTIONAL FOOD & BEVERAGE
9.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND
TABLE 53 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 54 FUNCTIONAL FOOD & BEVERAGE: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
9.4 PHARMACEUTICAL
9.4.1 GROWING APPLICATION TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET
TABLE 55 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 56 PHARMACEUTICAL: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
9.5 INFANT FORMULA
9.5.1 RISING CONSUMPTION OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND
TABLE 57 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 58 INFANT FORMULA: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
9.6 PET FOOD AND FEED
9.6.1 GREATER EMPHASIS ON BUILDING STRONG IMMUNITY IN PETS TO DRIVE MARKET
TABLE 59 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 60 PET FOOD AND FEED: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
10 OMEGA-3 MARKET, BY REGION
10.1 INTRODUCTION
FIGURE 36 INDIA TO RECORD FASTEST GROWTH IN GLOBAL OMEGA-3 MARKET
TABLE 61 OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 62 OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 63 OMEGA-3 MARKET, BY REGION, 2019–2023 (KT)
TABLE 64 OMEGA-3 MARKET, BY REGION, 2024–2029 (KT)
10.2 NORTH AMERICA
FIGURE 37 NORTH AMERICA: REGIONAL SNAPSHOT
10.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 38 OMEGA-3 MARKET IN NORTH AMERICA: RECESSION IMPACT ANALYSIS
TABLE 65 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 66 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 67 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 68 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 69 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 70 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 71 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 72 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 73 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 74 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
10.2.2 US
10.2.2.1 Growing demand for plant-based omega-3 dietary supplements to drive market
TABLE 75 US: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 76 US: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 77 US: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 78 US: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 79 US: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 80 US: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 81 US: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Increased application in functional food & beverages to boost demand
TABLE 82 CANADA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 83 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 84 CANADA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 85 CANADA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 86 CANADA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 87 CANADA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 88 CANADA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.2.4 MEXICO
10.2.4.1 Growing focus on preventing heart diseases to drive market
TABLE 89 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 90 MEXICO: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 91 MEXICO: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 92 MEXICO: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 93 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 94 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
FIGURE 39 OMEGA-3 MARKET IN EUROPE: RECESSION IMPACT ANALYSIS
TABLE 95 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 96 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 97 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 98 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 99 EUROPE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 100 EUROPE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 101 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 102 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 103 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 104 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
10.3.2 GERMANY
10.3.2.1 Less fish consumption to boost demand for omega-3-based supplements
TABLE 105 GERMANY: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 106 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 107 GERMANY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 108 GERMANY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 109 GERMANY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 110 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 111 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.3 UK
10.3.3.1 Ability to boost brain function and reduce inflammation to drive market
TABLE 112 UK: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 113 UK: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 114 UK: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 115 UK: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 116 UK: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 117 UK: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 118 UK: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Ongoing innovations to boost quality and stability of omega-3-rich oils formulation to drive market
TABLE 119 FRANCE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 120 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 121 FRANCE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 122 FRANCE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 123 FRANCE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 124 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 125 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.5 NORWAY
10.3.5.1 Production of genetically modified canola to offer lucrative growth opportunities to players
TABLE 126 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 127 NORWAY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 128 NORWAY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 129 NORWAY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 130 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 131 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.6 ITALY
10.3.6.1 High production of dietary supplements, functional food products, and beverages to boost demand
TABLE 132 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 133 ITALY: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 134 ITALY: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 135 ITALY: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 136 ITALY: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 137 ITALY: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.7 SPAIN
10.3.7.1 Need for sufficient consumption of ALA, DHA and EPA from foods to accelerate demand
TABLE 138 SPAIN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 139 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 140 SPAIN: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 141 SPAIN: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 142 SPAIN: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 143 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 144 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.8 NETHERLANDS
10.3.8.1 Growing incidences of depression, autism, and ADHD to drive market
TABLE 145 NETHERLANDS: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 146 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 147 NETHERLANDS: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 148 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 149 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 150 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 151 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.3.9 REST OF EUROPE
TABLE 152 REST OF EUROPE: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 153 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 154 REST OF EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 155 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 156 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 157 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 158 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 40 ASIA PACIFIC: REGIONAL SNAPSHOT
10.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 41 OMEGA-3 MARKET IN ASIA PACIFIC: RECESSION IMPACT ANALYSIS
TABLE 159 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 160 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 161 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 162 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 163 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 164 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
10.4.2 CHINA
10.4.2.1 Increasing focus on product innovations and diversifications to drive market
TABLE 169 CHINA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 170 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 171 CHINA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 172 CHINA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 173 CHINA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 174 CHINA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 175 CHINA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing incidences of heart failure to drive market
TABLE 176 INDIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 177 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 178 INDIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 179 INDIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 180 INDIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 181 INDIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 182 INDIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4.4 JAPAN
10.4.4.1 Rising use of innovative formulation technology to create opportunities for manufacturers of omega-3 products
TABLE 183 JAPAN: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 184 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 185 JAPAN: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 186 JAPAN: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 187 JAPAN: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 188 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 189 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Government-led initiatives to increase awareness regarding omega-3 to drive market
TABLE 190 AUSTRALIA: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 191 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 192 AUSTRALIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 193 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 194 AUSTRALIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 195 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 196 AUSTRALIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4.6 NEW ZEALAND
10.4.6.1 Increasing consumer awareness and government regulations for omega-3 supplements to drive market growth
TABLE 197 NEW ZEALAND: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 198 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 199 NEW ZEALAND: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 200 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 201 NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 202 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 203 NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 204 REST OF ASIA PACIFIC: DAILY INTAKE RECOMMENDATIONS OF OMEGA-3
TABLE 205 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 206 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 207 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 208 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 209 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 210 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.5 SOUTH AMERICA
10.5.1 SOUTH AMERICA: RECESSION IMPACT
FIGURE 42 OMEGA-3 MARKET IN SOUTH AMERIC: RECESSION IMPACT ANALYSIS, 2023
TABLE 211 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 212 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 213 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 214 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 215 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 216 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 217 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 218 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 219 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 220 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
10.5.2 BRAZIL
10.5.2.1 Rising demand for algal oils to drive market
TABLE 221 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 222 BRAZIL: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 223 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 224 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 225 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 226 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.5.3 ARGENTINA
10.5.3.1 Commercialization of omega-3 products to fuel market growth
TABLE 227 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 228 ARGENTINA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 229 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 230 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 231 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 232 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.5.4 REST OF SOUTH AMERICA
TABLE 233 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 234 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 235 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 236 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 237 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 238 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6 ROW
10.6.1 ROW: RECESSION IMPACT
FIGURE 43 OMEGA-3 MARKET IN ROW: RECESSION IMPACT ANALYSIS
TABLE 239 ROW: OMEGA-3 MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 240 ROW: OMEGA-3 MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 241 ROW: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 242 ROW: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 243 ROW: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 244 ROW: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 245 ROW: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 246 ROW: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 247 ROW: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (KT)
TABLE 248 ROW: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (KT)
10.6.2 AFRICA
TABLE 249 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 250 AFRICA: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 251 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 252 AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 253 AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 254 AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 255 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 256 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.2.1 South Africa
10.6.2.1.1 Prevalence of undernutrition among pregnant women and kids to drive demand
TABLE 257 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 258 SOUTH AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 259 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 260 SOUTH AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 261 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 262 SOUTH AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.2.2 Egypt
10.6.2.2.1 Improved pediatric health conditions to boost demand
TABLE 263 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 264 EGYPT: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 265 EGYPT: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 266 EGYPT: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 267 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 268 EGYPT: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.2.3 Nigeria
10.6.2.3.1 Rising prevalnce of artery diseases to boost demand
TABLE 269 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 270 NIGERIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 271 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 272 NIGERIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 273 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 274 NIGERIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.2.4 Rest of Africa
TABLE 275 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 276 REST OF AFRICA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 277 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 278 REST OF AFRICA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 279 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 280 REST OF AFRICA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.3 MIDDLE EAST
TABLE 281 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 282 MIDDLE EAST: OMEGA-3 MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 283 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 284 MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 285 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 286 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 287 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 288 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.3.1 Saudi Arabia
10.6.3.1.1 Ongoing innovations in omega-3 products to drive market
TABLE 289 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 290 SAUDI ARABIA: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 291 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 292 SAUDI ARABIA: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 293 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 294 SAUDI ARABIA: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.3.2 UAE
10.6.3.2.1 Increasing awareness among consumers about health products to drive market
TABLE 295 UAE: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 296 UAE: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 297 UAE: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 298 UAE: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 299 UAE: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 300 UAE: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.3.3 Qatar
10.6.3.3.1 Growing research on algae to boost demand
TABLE 301 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 302 QATAR: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 303 QATAR: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 304 QATAR: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 305 QATAR: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 306 QATAR: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
10.6.3.4 Rest of Middle East
TABLE 307 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 308 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 309 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 310 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 311 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 312 REST OF MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2024–2029 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS, 2022
TABLE 313 OMEGA-3 MARKET: DEGREE OF COMPETITION
11.3 KEY PLAYERS STRATEGIES/RIGHT TO WIN, 2020–2024
TABLE 314 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET, 2020–2024
11.4 BRAND/PRODUCT ANALYSIS
FIGURE 44 BRAND/PRODUCT ANALYSIS FOR KEY BRANDS
11.5 SEGMENTAL REVENUE ANALYSIS, 2020–2022
FIGURE 45 THREE-YEAR SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS IN OMEGA-3 MARKET (USD BILLION)
11.6 KEY PLAYERS’ ANNUAL REVENUE, 2022 VS. REVENUE GROWTH, 2020–2022
FIGURE 46 ANNUAL REVENUE, 2022 (USD BILLION) VS. REVENUE GROWTH (%), 2020–2022
11.7 EBIT/EBITDA ANALYSIS, 2022
FIGURE 47 EBIT/EBITDA (USD BILLION)
11.8 GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS, 2022
FIGURE 48 GLOBAL SNAPSHOT OF KEY PARTICIPANTS
11.9 COMPANY VALUATION AND FINANCIAL METRICS
FIGURE 49 COMPANY VALUATION OF FEW MAJOR COMPANIES
FIGURE 50 EV/EBITDA OF KEY COMPANIES
11.10 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2022
11.10.1 STARS
11.10.2 EMERGING LEADERS
11.10.3 PERVASIVE PLAYERS
11.10.4 PARTICIPANTS
FIGURE 51 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
11.10.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.10.5.1 Company footprint
TABLE 315 OVERALL COMPANY FOOTPRINT
11.10.5.2 Type footprint
TABLE 316 OMEGA-3 MARKET: BY TYPE FOOTPRINT
11.10.5.3 Source footprint
TABLE 317 OMEGA-3 MARKET: BY SOURCE FOOTPRINT
11.10.5.4 Application footprint
TABLE 318 OMEGA-3 MARKET: BY APPLICATION FOOTPRINT
11.10.5.5 Region footprint
TABLE 319 OMEGA-3 MARKET: BY REGION FOOTPRINT
11.11 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2022
11.11.1 PROGRESSIVE COMPANIES
11.11.2 RESPONSIVE COMPANIES
11.11.3 DYNAMIC COMPANIES
11.11.4 STARTING BLOCKS
FIGURE 52 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2022
11.11.5 COMPETITIVE BENCHMARKING, START-UPS/SMES, 2023
11.11.5.1 List of key start-ups/SMEs
TABLE 320 OMEGA-3 MARKET: LIST OF KEY START-UPS/SMES
11.11.5.2 Competitive benchmarking of key start-ups/SMEs
TABLE 321 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
11.12 COMPETITIVE SCENARIO
11.12.1 PRODUCT LAUNCHES
TABLE 322 OMEGA-3 MARKET: PRODUCT LAUNCHES, JANUARY 2020– FEBRUARY 2024
11.12.2 DEALS
TABLE 323 OMEGA-3 MARKET: DEALS, JANUARY 2020– FEBRUARY 2024
11.12.3 EXPANSIONS
TABLE 324 OMEGA-3 MARKET: EXPANSIONS, JANUARY 2020– FEBRUARY 2024
11.12.4 OTHERS
TABLE 325 OMEGA-3 MARKET: OTHERS, JANUARY 2020– FEBRUARY 2024
12 COMPANY PROFILES
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 KEY PLAYERS
12.1.1 BASF SE
TABLE 326 BASF SE: COMPANY OVERVIEW
FIGURE 53 BASF SE: COMPANY SNAPSHOT
TABLE 327 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 328 BASF SE: PRODUCT LAUNCHES
12.1.2 CARGILL, INCORPORATED
TABLE 329 CARGILL, INCORPORATED: COMPANY OVERVIEW
FIGURE 54 CARGILL, INCORPORATED.: COMPANY SNAPSHOT
TABLE 330 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 331 CARGILL, INCORPORATED: DEALS
12.1.3 DSM-FIRMENICH
TABLE 332 DSM-FIRMENICH: COMPANY OVERVIEW
FIGURE 55 DSM-FIRMENICH: COMPANY SNAPSHOT
TABLE 333 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 334 DSM-FIRMENICH: PRODUCT LAUNCHES
12.1.4 ADM
TABLE 335 ADM: COMPANY OVERVIEW
FIGURE 56 ADM: COMPANY SNAPSHOT
TABLE 336 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.1.5 KERRY GROUP PLC
TABLE 337 KERRY GROUP PLC: BUSINESS OVERVIEW
FIGURE 57 KERRY GROUP PLC: COMPANY SNAPSHOT
TABLE 338 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 339 KERRY GROUP PLC: DEALS
12.1.6 CRODA INTERNATIONAL PLC
TABLE 340 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW
FIGURE 58 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
TABLE 341 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.1.7 ORKLA
TABLE 342 ORKLA: COMPANY OVERVIEW
FIGURE 59 ORKLA: COMPANY SNAPSHOT
TABLE 343 ORKLA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 344 ORKLA: DEALS
12.1.8 CORBION
TABLE 345 CORBION: COMPANY OVERVIEW
FIGURE 60 CORBION: COMPANY SNAPSHOT
TABLE 346 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 347 CORBION: PRODUCT LAUNCHES
TABLE 348 CORBION: EXPANSIONS
12.1.9 PELAGIA AS
TABLE 349 PELAGIA AS: COMPANY OVERVIEW
FIGURE 61 PELAGIA AS: COMPANY SNAPSHOT
TABLE 350 PELAGIA AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 351 PELAGIA AS: DEALS
12.1.10 KD PHARMA GROUP SA
TABLE 352 KD PHARMA GROUP SA: COMPANY OVERVIEW
TABLE 353 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 354 KD PHARMA GROUP SA: EXPANSIONS
12.1.11 GC RIEBER
TABLE 355 GC RIEBER: COMPANY OVERVIEW
TABLE 356 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 357 GC RIEBER: PRODUCT LAUNCHES
TABLE 358 GC REIBER: DEALS
TABLE 359 GC RIEBER: EXPANSIONS
12.1.12 COOKE AQUACULTURE INC.
TABLE 360 COOKE AQUACULTURE INC.: COMPANY OVERVIEW
TABLE 361 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 362 COOKE AQUACULTURE INC.: DEALS
12.1.13 ALGISYS BIOSCIENCES, INC.
TABLE 363 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW
TABLE 364 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 365 ALGISYS BIOSCIENCES, INC.: OTHERS
12.1.14 GOLDEN OMEGA
TABLE 366 GOLDEN OMEGA: COMPANY OVERVIEW
TABLE 367 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 368 GOLDEN OMEGA: DEALS
12.1.15 POLARIS
TABLE 369 POLARIS: COMPANY OVERVIEW
TABLE 370 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 371 POLARIS: PRODUCT LAUNCHES
TABLE 372 POLARIS: OTHERS
12.2 OTHER PLAYERS
12.2.1 BTSA
TABLE 373 BTSA: COMPANY OVERVIEW
TABLE 374 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.2.2 FARBEST BRANDS
TABLE 375 FARBEST BRANDS: COMPANY OVERVIEW
TABLE 376 FARBEST BRANDS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.2.3 KINOMEGA BIOPHARM INC.
TABLE 377 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW
TABLE 378 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.2.4 PHARMA MARINE AS
TABLE 379 PHARMA MARINE AS: COMPANY OVERVIEW
TABLE 380 PHARMA MARINE AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.2.5 RIMFROST AS
TABLE 381 RIMFROST AS: COMPANY OVERVIEW
TABLE 382 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 383 RIMFROST AS: DEALS
12.2.6 ALGARITHM
12.2.7 SOLUTEX
12.2.8 CELLANA INC.
12.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD
12.2.10 ALGAECYTES
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 ADJACENT AND RELATED MARKETS
13.1 INTRODUCTION
TABLE 384 ADJACENT MARKETS
13.2 LIMITATIONS
13.3 COLLAGEN MARKET
13.3.1 MARKET DEFINITION
13.3.2 MARKET OVERVIEW
TABLE 385 COLLAGEN MARKET, BY FORM, 2019–2022 (USD MILLION)
TABLE 386 COLLAGEN MARKET, BY FORM, 2023–2030 (USD MILLION)
13.4 ALGAE PRODUCTS MARKET
13.4.1 MARKET DEFINITION
13.4.2 MARKET OVERVIEW
TABLE 387 ALGAE PRODUCTS MARKET, BY SOURCE, 2018–2022 (USD MILLION)
TABLE 388 ALGAE PRODUCTS MARKET, BY SOURCE, 2023–2028 (USD MILLION)
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
This report defines and segments the "Omega-3 PUFA Market by Type (DHA, EPA, ALA), Source[Marine (Fish, Algal, Krill, Others), Plant (Flaxseed, Chia Seed, Others)], Application (Dietary supplement, Functional F&B, Pharma, Infant Formula, Others) & Geography - Global Trend & Forecast to 2019", with analyses and projections of the market size, in terms of value and volume.
The global Omega-3 PUFA market was valued at $2105.0 Million in 2013 and is expected to reach $4336.2 Million by 2019, at a CAGR of 12.8% from 2014 to 2019.
The Omega-3 PUFA market is projected to grow at a healthy CAGR of 12.8% between 2014 and 2019. Dietary supplements as an application garner the largest market share of 55%, followed by functional food & beverage and pharmaceuticals. As there is a growing demand amongst consumers for healthy ingredients fortified into food and beverage to prevent disease, the functional food & beverage sector is growing at a considerable rate. The pharmaceutical and infant formula category is also expected to exhibit a robust growth rate in the next five years. Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA) dominate the Omega- 3 PUFA market, by type, and fish oils are the largest and dominant sources as they are rich in EPA and DHA.
The Omega-3 PUFA market is expanding at a significant rate. North America is the largest market for Omega-3 PUFA, due to the demand for functional foods & beverages and technological advancements. In Europe, regulations favor the usage of Omega-3 PUFA in functional foods and infant formula and are expected to spur the demand in its developed markets.
The Asia-Pacific region has huge market potential for Omega-3 PUFA as consumer awareness about Omega-3 PUFA’s preventive healthcare benefits has increased and there is a rising occurrence of cardiovascular disease. The presence of a favorable government regulatory environment for safer and healthy products further boosts the Asia-Pacific market.
The key players in the market are:
- BASF (Germany)
- DSM (The Netherlands)
- Croda International PLC (U.K.)
- Omega Protein Corp (U.S.)
